BridgeMD
New treatment option for Stroke Hemorrhagic
Official title The Role of Cognition in Motor Learning After Stroke
ClinicalTrials.gov ID: NCT05268861
What this study is testing
- What it's testing
- Stroke leads to lasting problems in using the upper limb (UL) for everyday life activities. While rehabilitation programs depend on motor learning, UL recovery is less than ideal.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Sustained a first cortical/sub-cortical ischemic/hemorrhagic stroke less than 3 years previously and are medically stable.
- Are no longer receiving treatment.
- Normal or corrected-to-normal vision.
- Have arm paresis (Chedoke-McMaster Arm Scale 2-6/7) and spasticity (Modified Ashworth Scale ≥ 1/4) but can voluntarily flex/extend the elbow to...
You likely can't join if
- Other major neurological or musculoskeletal problems that may interfere with task performance.
- Marked elbow proprioceptive deficits (\<6/12 Fugl-Meyer UL sensation scale) that may interfere with elbow position perception.
- Visuospatial neglect (Line Bisection Test deviation \> 6 mm).
- Uncorrected vision.
- Depression (≥ 14 Beck Depression Inventory II).
The study team makes the final eligibility decision.
Where it's taking place
- Laval, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Laval, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.